Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Potential BPH therapy from Abbott

April 16, 1997

No Comments

New COX-2 inhibitor from Searle

April 15, 1997

No Comments

Eisai prepares potent antitumor agents

April 11, 1997

No Comments

TX-1877: new hypoxic cell radiation enhancer

April 11, 1997

No Comments

Fujisawa describes new oral cephem antibiotic

April 11, 1997

No Comments

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

No Comments

MDR-reversing agents described by Nikken Chemicals

April 11, 1997

No Comments

New LTD4 antagonist from Fujisawa

April 10, 1997

No Comments

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

No Comments

Senju describes new calpain inhibitor

April 10, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

New compound, BioWorld Science
RSS

Potential BPH therapy from Abbott

New COX-2 inhibitor from Searle

Eisai prepares potent antitumor agents

TX-1877: new hypoxic cell radiation enhancer

Fujisawa describes new oral cephem antibiotic

Fujsawa selects adenosine A1 receptor antagonist for development

MDR-reversing agents described by Nikken Chemicals

New LTD4 antagonist from Fujisawa

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

Senju describes new calpain inhibitor

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Radiopharma Telix acquires FAP-targeting agents for bladder cancer

New compound, BioWorld Science RSS

New compound, BioWorld Science
RSS